Health / Medical Topics

    BARD1 Pathway

    BRCA1 is a breast and ovarian cancer tumor suppressor protein that associates with BARD1 to form a RING/RING heterodimer. The BRCA1/BARD1 RING complex functions as an ubiquitin (Ub) ligase with activity substantially greater than individual BRCA1 or BARD1 subunits. The BRCA1 tumor suppressor forms a heterodimer with the BARD1 protein, and the resulting complex functions as an E3 ubiquitin ligase that catalyzes the synthesis of polyubiquitin chains. UbcH5c and UbcH7 also interact with the BRCA1/BARD1 complex with similar affinity (not shown on this figure). Although the in vivo substrate(s) is not yet known, BRCA1 has been observed to undergo autoubiquitination and is capable of monoubiquitinating histones 2A and 2AX in vitro. (NCI Thesaurus/BIOCARTA)




    YOU MAY ALSO LIKE

    This gene plays a role in cellular response and is susceptible to oncogenic mutations in breast and ovarian cancers.
    A machine-readable representation of information in a visual format on a surface.
    A method to diagnosis hepatocellular carcinoma based on radiological findings, alfa-fetoprotein level and biopsy.
    The determination of the amount of barbiturate class agents present in a sample.
    A type of drug that causes a decrease in brain activity. Barbiturates may be used to treat insomnia, seizures, and convulsions, and…
    The goal of the Barbara Ann Karmanos Cancer Institute is the ultimate prevention and cure of cancer. The Center's programs are directed…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact